# Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD

> **NCT03623282** · PHASE4 · COMPLETED · sponsor: **Ahn-Gook Pharmaceuticals Co.,Ltd** · enrollment: 30 (actual)

## Conditions studied

- Bronchitis, COPD

## Interventions

- **DRUG:** Synatura® 15 mL

## Key facts

- **NCT ID:** NCT03623282
- **Lead sponsor:** Ahn-Gook Pharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-17
- **Primary completion:** 2018-05-02
- **Final completion:** 2018-05-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03623282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03623282, "Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03623282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*